--- title: "Sbc Medical Group Holdings Chairman, CEO Sold Shares Worth Over $9.3M" type: "News" locale: "en" url: "https://longbridge.com/en/news/283908968.md" description: "Aikawa Yoshiyuki, Chairman and CEO of Sbc Medical Group Holdings and a 10% owner, sold 3,100,000 shares of common stock on April 21, 2026, for a total of $9,369,750 at a net price of $3.0225 per share. Post-transaction, he directly owns 79,304,460 shares and indirectly owns 5,861,600 shares through other entities, as reported in SEC Form 4." datetime: "2026-04-24T00:10:01.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/283908968.md) - [en](https://longbridge.com/en/news/283908968.md) - [zh-HK](https://longbridge.com/zh-HK/news/283908968.md) generator: "portal-rs" --- # Sbc Medical Group Holdings Chairman, CEO Sold Shares Worth Over $9.3M Aikawa Yoshiyuki, a 10% owner serving as Chairman and CEO, sold 3,100,000 shares of common stock on April 21, 2026. The net price received per share was $3.0225. The total sale amount was $9,369,750. After the transaction, Aikawa directly owned 79,304,460 shares and indirectly owned 5,861,600 shares via entities noted in the filing. Reporter Name Aikawa Yoshiyuki Relationship Chairman and CEO, 10% Owner Type Sell Amount $9,369,750 SEC Filing FormĀ 4 **Disclaimer** This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC. ### Related Stocks - [SBC.US](https://longbridge.com/en/quote/SBC.US.md) - [SBCWW.US](https://longbridge.com/en/quote/SBCWW.US.md) ## Related News & Research - [SBC Medical to Participate in Several Upcoming Investor Conferences in September 2026 | SBC Stock News](https://longbridge.com/en/news/297683389.md) - [Q3 Virtual Investor Summit Presentations Now Available On Demand](https://longbridge.com/en/news/297567593.md) - [Security Risk Advisors Launches SCALR AI as a Free SOC AI Platform for Security Teams](https://longbridge.com/en/news/297523531.md) - [SBC: 2Q 2026 saw 13% revenue growth and 335% net income surge, with strong global expansion plans](https://longbridge.com/en/news/295781152.md) - [SBC: Leading Japanese aesthetic clinic group achieves rapid global growth and strong financial results](https://longbridge.com/en/news/296358670.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**